Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Research Square|February 12, 2026
CAR Signaling Informs Mechanisms to Enhance Metabolism and Function in γδ T CellsDaniel Abate-Daga, Xiomar Bustos Perez, Leticia Tordesillas, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Engineering synthetic agonists for targeted activation of Notch signalingDavid H Perez, Daniel Antfolk, Xiomar E Bustos, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 9, 2017
Experimental Treatments for Leptomeningeal Metastases From Solid MalignanciesSolmaz Sahebjam, Peter A Forsyth, Keiran S Smalley, et al.
Nature Chemical Biology|September 24, 2025
Engineering synthetic agonists for targeted activation of Notch signalingDavid H Perez, Daniel Antfolk, Shiun Chang, et al.
Journal of Neuro-Oncology|March 5, 2011
Leptomeningeal disease in oligodendroglial tumors: a population-based studyGloria Roldán, Jennifer Chan, Misha Eliasziw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 28, 2025
Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)Anna E Coghill, Nathan Van Bibber, Robert A Baiocchi, et al.
Cancers|March 29, 2023
Leptomeningeal Disease (LMD) in Patients with Melanoma MetastasesMariam Lotfy Khaled, Ahmad A Tarhini, Peter A Forsyth, et al.
Journal of Neuro-Oncology|August 12, 2009
Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experienceShelly Lwu, Mark G Hamilton, Peter A Forsyth, et al.
Cytokine & Growth Factor Reviews|May 21, 2010
Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devilFranz J Zemp, Juan Carlos Corredor, Xueqing Lun, et al.
Journal for Immunotherapy of Cancer|September 9, 2014
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cellsRachel E Beard, Zhili Zheng, Kiran H Lagisetty, et al.
Pageof 15